Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Endpoint summary

Currently viewing:

Administrative data

Key value for chemical safety assessment

Effects on fertility

Effect on fertility: via oral route
Endpoint conclusion:
no adverse effect observed
Species:
rabbit
Effect on fertility: via inhalation route
Endpoint conclusion:
no study available
Effect on fertility: via dermal route
Endpoint conclusion:
no study available
Additional information

Naproxen given orally up to 60 mg/kg/day to pregnant rabbits did not affect fertility, gestation or number of live fetuses.

Effects on developmental toxicity

Effect on developmental toxicity: via oral route
Endpoint conclusion:
adverse effect observed
Species:
rat
Effect on developmental toxicity: via inhalation route
Endpoint conclusion:
no study available
Effect on developmental toxicity: via dermal route
Endpoint conclusion:
no study available
Additional information

Naproxen given orally to pregnant rats up to 20 mg/kg/day did not result in adverse effects in viability of pups, lactation index, sex ratio, or weight gain of offspring; however, slight increases in gestation length and significant increases in stillbirths was seen at > 10 mg/kg. Fetal deaths seen in naproxen-treated rats were apparently related to dystocia rather than to a direct toxic effect of the drug, as similar effects were observed with other commonly used nonsteroidal anti-infiammatory agents in the rat.

Justification for classification or non-classification

Additional information